Cited by 1,395Blood Pressure and Hypertension StudiesSodium Intake and HealthHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.

Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004

Ong, Kwok Leung, Cheung, Bernard M.Y., Man, Yu Bun, Lau, Chu Pak, Lam, Karen S.L.·2007·Hypertension

DOI 10.1161/01.hyp.0000252676.46043.18

Open this paper in CoChat — free account

Abstract

Detection of hypertension and blood pressure control are critically important for reducing the risk of heart attacks and strokes. We analyzed the trends in the prevalence, awareness, treatment, and control of hypertension in the United States in the period 1999–2004. We used the National Health and Nutrition Examination Survey 1999–2004 database. Blood pressure information on 14 653 individuals (4749 in 1999–2000, 5032 in 2001–2002, and 4872 in 2003–2004) aged ≥18 years was used. Hypertension was defined as blood pressure ≥140/90 mm Hg or taking antihypertensive medications. The prevalence of hypertension in 2003–2004 was 7.3±0.9%, 32.6±2.0%, and 66.3±1.8% in the 18 to 39, 40 to 59, and ≥60 age groups, respectively. The overall prevalence was 29.3%. When compared with 1999–2000, there were nonsignificant increases in the overall prevalence, awareness, and treatment rates of hypertension. The blood pressure control rate was 29.2±2.3% in 1999–2000 and 36.8±2.3% in 2003–2004. The age-adjusted increase in control rate was 8.1% (95% CI: 2.4 to 13.8%; P =0.006). The control rates increased significantly in both sexes, non-Hispanic blacks, and Mexican Americans. Among the ≥60 age group, the awareness, treatment, and control rates of hypertension had all increased significantly ( P ≤0.01). The improvement in blood pressure control is encouraging, although the prevalence of hypertension has not declined.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000252676.46043.18

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
(1998) · BMJ · doi:10.1136/bmj.317.7160.703 · Cited by 6,683
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Smit, E. (2003) · Human Kinetics eBooks · doi:10.5040/9781718206601.ch-001 · Cited by 4,382
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L., Hua, T. A., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,557
Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000
Hajjar, I. M. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,399

Show all 35 references

Research works printed but not linked: 4

Plan and operation of the Third National Health and Nutrition Examination Survey 1988–94. Vital Health Stat 1. 1994; 32: 1–407.
10.1161/circ.88.5.8222141 · DOI
Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People 2010. Stat Notes. 2001; 20: 1–10.
US Department of Health and Human Services. Healthy People 2010 (conference ed in 2 vols). Washington DC: US Department of Health and Human Services; 2000. Available at: http://www.health.gov/healthypeople. Accessed April 24 2006.

Sorted by citations

Items 701–800 of 1,000

Impact of Comorbidities on Racial/Ethnic Disparities in Hypertension in the United States
Opara, F., Hawkins, K., Sundaram, A., Merchant, M., Rasmussen, S., & Holmes, L. (2013) · ISRN Public Health · doi:10.1155/2013/967518 · Cited by 16
Efficacy of an Olmesartan Medoxomil–Based Treatment Algorithm in Patients Stratified by Age, Race, or Sex
Oparil, S., & Pimenta, E. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00217.x · Cited by 16
Nebivolol in High‐Risk, Obese African Americans With Stage 1 Hypertension: Effects on Blood Pressure, Vascular Compliance, and Endothelial Function
Merchant, N., Searles, C. D., Pandian, A., Rahman, S. T., Ferdinand, K. C., Umpierrez, G. E., & Khan, B. V. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00198.x · Cited by 16
Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence
McGill, J. B. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6668 · Cited by 16
Hypertension Control in the Elderly
Neutel, J. M., & Gilderman, L. I. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.08030.x · Cited by 16
Arterial vasodilatory and ventricular diastolic reserves determine the stroke volume response to exercise in elderly female hypertensive patients
Sahlén, A., Abdula, G., Norman, M., Manouras, A., Brodin, L., Lund, L. H., Shahgaldi, K., & Winter, R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00555.2011 · Cited by 16
Hypertension treatment update: Focus on direct renin inhibition
Fitzgerald, M. A. (2011) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2010.00589.x · Cited by 17
“In addition, BP control, defined as < 140/90 mmHg in patients with uncomplicated hypertension, remains low (33% in the United States; Ong et al., 2007).”
BackgroundInfluential
Lifestyle Changes and Blood Pressure Control: A Community‐Based Cross‐Sectional Survey (2006 Ontario Survey on the Prevalence and Control of Hypertension)
Fodor, G. J., McInnis, N. H., Helis, E., Turton, P., & Leenen, F. H. H. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00059.x · Cited by 16
Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis
Lee, A. C., Li, W. T., Apostol, L., Ma, J., Taub, P. R., Chang, E. Y., Rajasekaran, M. R., & Ongkeko, W. M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.038 · Cited by 16
“This is not unexpected as hypertension is a major risk factor for myocardial infarction, stroke, heart failure, and renal failure [22,23].”
Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer
Engelen, M. J. A., Snel, B. J., Schaapveld, M., Pras, E., de Vries, E. G. E., Gietema, J. A., van der Zee, A. G. J., & Willemse, P. H. B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.006 · Cited by 16
The association of language with prevalence of undiagnosed hypertension among older Mexican Americans.
Eamranond, P. P., Patel, K. V., Legedza, A., Marcantonio, E. R., & Leveille, S. G. (2007) · PubMed · Cited by 16
Beta-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults
Kelsey, R. M., Alpert, B. S., Dahmer, M. K., Krushkal, J., & Quasney, M. W. (2010) · Psychophysiology · doi:10.1111/j.1469-8986.2010.01006.x · Cited by 16
Calibration and Discrimination Among Multiple Cardiovascular Risk Scores in a Modern Multiethnic Cohort
DeFilippis, A. P., Young, R. L., & Blaha, M. J. (2015) · Annals of Internal Medicine · doi:10.7326/l15-5105-2 · Cited by 16
Drug Treatment of Obesity in Cardiovascular Disease
Charakida, M., & Finer, N. (2012) · American Journal of Cardiovascular Drugs · doi:10.2165/11599000-000000000-00000 · Cited by 17
Renal Transplantation from Elderly Living Donors
Akoh, J. A., & Thiyagarajan, U. M. (2013) · Journal of Transplantation · doi:10.1155/2013/475964 · Cited by 15
“This finding is similar to another study using the database of the National Health and Nutrition Examination Survey [41], which showed the prevalence of hypertension (defined as≥140/90mmHg or taking antihypertensivemedications) to be 7.”
ResultInfluential
Economic evaluation of four angiotensin II receptor blockers in the treatment of hypertension
Miller, L.-A., Wade, R. L., Dai, D., Cziraky, M. J., Ramaswamy, K., & Panjabi, S. S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003711045 · Cited by 15
The rising prevalence of self-reported hypertension among Chinese subjects: a population-based study from 121 895 household interviews
Wong, M. C. S., Wang, H., Leung, M. C. M., Tsang, C. S., Lo, S. V., & Griffiths, S. M. (2014) · QJM · doi:10.1093/qjmed/hcu129 · Cited by 15
Asociación y efectos de interacción en los genes AGT, AGTR1, ACE, ADRB2, DRD1, ADD1, ADD2, ATP2B1, TBXA2R y PTGS2 sobre la hipertensión en población antioqueña
Valencia, D. M., Naranjo, C. A., Parra, M. V., Antonieta, M., Valencia, A., Jaramillo, C. J., & Bedoya, G. (2013) · Biomédica · doi:10.7705/biomedica.v33i4.1489 · Cited by 15
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus
Reboldi, G., Gentile, G., Angeli, F., & Verdecchia, P. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.133 · Cited by 17
Aliskiren/valsartan combination for the treatment of cardiovascular and renal diseases
Yarows, S. A. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.143 · Cited by 15
Awareness, Treatment and Control of Hypertension and Related Factors in the Jurisdictional Areas of Primary Health Care Posts in a Rural Community of Korea
Lee, H. M., Kim, Y., Lee, C. H., Shin, J., Kim, M. K., & Choi, B. Y. (2011) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2011.44.2.74 · Cited by 15
A randomized controlled trial of negative co-payments: the CHORD trial.
Kg, V., Troxel, A. B., Ja, L., Ibrahim, S. A., Appleby, D., Smith, J. O., Jaskowiak, J., Helweg‐Larsen, M., Ja, D., & Se, K. (2015) · PubMed · Cited by 15
Race/ethnicity determines the relationships between oxidative stress markers and blood pressure in individuals with high cardiovascular disease risk
Kapuku, G. K., Treiber, F. A., Raouane, F., Halbert, J. D., Davis, H., Young-Mayes, S., Robinson, V., & Harshfield, G. A. (2016) · Journal of Human Hypertension · doi:10.1038/jhh.2016.39 · Cited by 14
Peroxisome proliferator-activated receptor-γ polymorphism (rs1801282) is associated with obesity in Egyptian patients with coronary artery disease and type 2 diabetes mellitus
Hasan, N. S., Kamel, S. A., Hamed, M., Awadallah, E. A., Rahman, A. H. A., Musa, N. I., & Hussein, G. (2017) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2017.08.002 · Cited by 15
Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003‐2014
Sonawane, K., Zhu, Y., Balkrishnan, R., Suk, R., Sharrief, A. Z., Deshmukh, A. A., & Aguilar, D. A. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13553 · Cited by 15
Blood pressure control in primary care patients with arterial hypertension: analysing the Hypertension Register data
Posnenkova, O. M., Kiselev, A. R., Gridnev, V. I., Schwartz, V. A., Dovgalevskyi, P. Y., & Ощепкова, Е. В. (2012) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2012-3-4-11 · Cited by 15
Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years
Gradman, A. H. (2009) · Drugs & Aging · doi:10.2165/11316790-000000000-00000 · Cited by 15
Trends in Serum Lipids and Hypertension Prevalence Among Non-Pregnant Reproductive-Age Women: United States National Health and Nutrition Examination Survey 1999–2008
Laz, T. H., Rahman, M., & Berenson, A. B. (2012) · Maternal and Child Health Journal · doi:10.1007/s10995-012-1148-y · Cited by 15
“The selfreported rates of receiving clinicians’ advice to use antihypertensive medications and patients’ compliance with these medications were consistent with the findings reported by several other studies based on data from different NHANES cycles [21, 31, 38].”
The Management of Acute Hypertension in Patients With Renal Dysfunction: Labetalol or Nicardipine?
Varón, J., Soto‐Ruiz, K. M., Baumann, B. M., Borczuk, P., Cannon, C. M., Chandra, A., Cline, D. M., Diercks, D. B., Hiestand, B. C., Hsu, A., et al. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2790 · Cited by 15
Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments
Marcatto, F., Rolison, J. J., & Ferrante, D. (2013) · Judgment and Decision Making · doi:10.1017/s1930297500004472 · Cited by 15
Hypertension management in Canada: good news, but important challenges remain
Mohan, S., & Campbell, N. R. C. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080296 · Cited by 15
“is reassuring that the ON-BP study found similar levels of treatment and control in different ethnic groups, an issue the American health care system has not yet successfully dealt with.(9)”
Result
BEWARE OF BEING UNAWARE: RACIAL/ETHNIC DISPARITIES IN CHRONIC ILLNESS IN THE USA
Chatterji, P., Joo, H., & Lahiri, K. (2012) · Health Economics · doi:10.1002/hec.2856 · Cited by 15
Low-dose Estrogen Is as Effective as High-dose Treatment in Rats With Postmenopausal Hypertension
Carraro, C. C., Sartório, C. L., Casali, K. R., Fernandes, R. O., Llesuy, S., Araújo, A. S. D. R., Belló‐Klein, A., & Rigatto, K. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000034 · Cited by 15
Management of cardiovascular risk with RAS inhibitor/CCB combination therapy
Dahlöf, B. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.88 · Cited by 15
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus
Derosa, G., Querci, F., Franzetti, I., Ragonesi, P. D., D’Angelo, A., & Maffioli, P. (2015) · Hypertension Research · doi:10.1038/hr.2015.57 · Cited by 14
Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia
Kefale, B., Tegegne, G. T., Kefale, Y., Molla, M., Ewunetei, A., & Degu, A. (2020) · SAGE Open Medicine · doi:10.1177/2050312120954695 · Cited by 14
Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results
Izzo, J. L., WEINTRAUB, H. S., Duprez, D. A., Purkayastha, D., Zappe, D., Samuel, R., & Cushman, W. C. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00498.x · Cited by 14
Improving blood pressure control rates by optimizing combination antihypertensive therapy
Epstein, B. J. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.500614 · Cited by 14
Prevalence of Undiagnosed and Inadequately Treated Type 2 Diabetes Mellitus, Hypertension, and Dyslipidemia in Morbidly Obese Patients Who Present for Bariatric Surgery
Mostaedi, R., Lackey, D. E., Adams, S. H., Dada, S. A., Hoda, Z. A., & Ali, M. R. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1196-z · Cited by 14
Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients
Guthrie, R. M., Dahlöf, B., Jamerson, K., Olvera, R., Seeber, M., Schumacher, H., Oigman, W., & on behalf of the study investigators (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.616490 · Cited by 14
Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension
Chrysant, S. G., Murray, A. V., Hoppe, U. C., Dattani, D., PATEL, S. N., Ritter, S., & Zhang, J. Y. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.528282 · Cited by 14
Trend of hypertension morbidity and mortality in Tigray Region from 2011 to 2015, Tigray, Ethiopia
Gerensea, H., & Teklay, H. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3488-1 · Cited by 13
Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE‐ON study
Ohkuma, T., Peters, S. A. E., Jun, M., Harrap, S. B., Cooper, M. E., Hamet, P., Poulter, N. R., Chalmers, J. P., Woodward, M., & the ADVANCE Collaborative Group (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14103 · Cited by 15
Aging impairs arterial compliance via Klotho-mediated downregulation of B-cell population and IgG levels
Fan, J., Wang, S., Chen, K., & Sun, Z. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04512-x · Cited by 15
Heart Failure
Lee, C. S., & Auld, J. P. (2015) · Critical Care Nursing Clinics of North America · doi:10.1016/j.cnc.2015.07.009 · Cited by 14
Initial Combination Therapy With Irbesartan/Hydrochlorothiazide for Hypertension: An Analysis of the Relationship Between Baseline Blood Pressure and the Need for Combination Therapy
Franklin, S. S., Lapuerta, P., Cox, D., & Donovan, M. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.07808.x · Cited by 14
Role of the fixed-dose combination lercanidipine–enalapril in renal protection
Egan, C. G., & Pontremoli, R. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.6271 · Cited by 14
Prevalencia, grado de conocimiento y control de la hipertensión arterial en una población española. Estudio MADRIC (Madrid Riesgo Cardiovascular)
Castell-Alcalá, M. V., Martı́nez, M. A., Sanz, J., & Puig, J. G. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.03.016 · Cited by 14
Misclassification and discordance of measured blood pressure from patient’s true blood pressure in current clinical practice: a clinical trial simulation case study
Jin, Y., Bies, R. R., Gastonguay, M. R., Stockbridge, N., Gobburu, J. V. S., & Madabushi, R. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9250-8 · Cited by 14
National Utilization of Antihypertensive Medications From 2000 to 2006 in the Veterans Health Administration: Focus on Thiazide Diuretics
Furmaga, E. M., Cunningham, F. E., Cushman, W. C., Dong, D., Jiang, R., BASILE, J. N., Katz, L. A., Rutan, G. H., Berlowitz, D. R., Papademetriou, V., et al. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00019.x · Cited by 14
Prevalence, Healthcare Utilization, and Costs of Breast Cancer in a State Medicaid Fee-for-Service Program
Khanna, R., Madhavan, S. S., Bhanegaonkar, A. J., & Remick, S. C. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2298 · Cited by 14
The Role of Fixed-Dose Combination Therapy with Drugs that Target the Renin-Angiotensin System in the Hypertension Paradigm
Schmieder, R. E. (2010) · Clinical and Experimental Hypertension · doi:10.3109/10641960902960532 · Cited by 14
“While the percentage of patients meeting these guideline targets has increased in recent years (3, 7), the vast majority of patients will require two or more antihypertensive agents from different classes (3, 6, 8–10).”
Background
Impact of Medication Adherence on Work Productivity in Hypertension
Wagner, S., Lau, H., Frech‐Tamas, F., & Gupta, S. (2012) · Cited by 14
I RBH - First Brazilian Hypertension Registry
Jardim, P. C. B. V., Barroso, W. K. S., Lópes, R. D., Brandão, A. A., Malachias, M. V. B., Gomes, M. M., Moreno, H., Barbosa, E. C. D., & Póvoa, R. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160120 · Cited by 14
Incident Strokes Among American Indian Individuals With Atrial Fibrillation
Sánchez, J. M., Jolly, S. E., Dewland, T. A., Tseng, Z. H., Nah, G., Vittinghoff, E., & Marcus, G. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.120.019581 · Cited by 13
Combination Therapy With an Angiotensin‐Converting Enzyme Inhibitor and a Calcium Channel Blocker
Egan, B. M. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2007.tb00005.x · Cited by 14
Prompt, Aggressive BP Lowering in High‐Risk Patients
Jamerson, K., & BASILE, J. N. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.08145.x · Cited by 14
Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure
Coca, A. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s6561 · Cited by 14
Gender Disparities in Hypertension Among Different Ethnic Groups in Amsterdam, The Netherlands: The SUNSET Study
Agyemang, C. O., de Munter, J. S., van Valkengoed, I. G. M., van den Born, B. H., & Stronks, K. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.227 · Cited by 14
Cost‐effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial‐based analysis
Glasziou, P., Clarke, P., Alexander, J., Rajmokan, M., Beller, E., Woodward, M., Chalmers, J. P., Poulter, N. R., & Patel, A. A. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03941.x · Cited by 14
Influence of Altered Blood Rheology on Ventricular-Vascular Response to Exercise
Sharman, J. E., Brown, J. K., Holland, D. J., Macdonald, G. A., Kostner, K., & Marwick, T. H. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135525 · Cited by 14
“The prevalence of hypertension markedly increases with advancing age, such that it affects 66% of individuals over 60 yr of age ( 56 ).”
Background
Effectiveness of Valsartan for Treatment of Hypertension: Patient Profiling and Hierarchical Modeling of Determinants and Outcomes (the Preview Study)
der Niepen, P. V., Woestenburg, A., Brié, H., Vancayzeele, S., MacDonald, K., Denhaerynck, K., Lee, C. S., Hermans, C., & Abraham, I. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l576 · Cited by 15
Aliskiren–hydrochlorothiazide combination for the treatment of hypertension
Chrysant, S. G. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.305 · Cited by 13
Cardiovascular risk and blood pressure control in a Spanish hypertensive population attended in a Primary Care setting. Data from the PRESCAP 2006 study
Rodríguez-Roca, G. C., Llisterri-Caro, J. L., Barrios, V., Alonso-Moreno, F. J., Arnal, S. L., Prieto-Díaz, M. Á., Ruiz, T. S., Belinchón, R. D., Santos-Rodriguez, J. A., Divisón, J. A., et al. (2009) · Blood Pressure · doi:10.1080/08037050902982292 · Cited by 13
Hypertension Prevalence and Prescribing Trends in Older US Adults: 1999–2004
Aslam, F., Haque, A., Agostini, J. V., Wang, Y., & Foody, J. M. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00223.x · Cited by 13
Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal
Morgado, M., Rolo, S., Pereira, L. C., & Castelo-Branco, M. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-349 · Cited by 13
Personality Traits, Clinical Characteristics, and Health‐Related Quality of Life of Patients with Hypertension in a Primary Hospital in Ghana
Kretchy, I. A., Acheampong, F., Laryea, J., Osafo, J., Asampong, E., & Dickson, E. D. (2019) · International Journal of Hypertension · doi:10.1155/2019/7489875 · Cited by 13
“This may be because hypertension is more common in the elderly [37] and as age increases the period of having hypertension is also prolonged resulting in a build-up of factors that could negatively impact on particularly the physical aspect of quality of life of a patient over a period.”
Background
Glycemic control among ambulatory type 2 diabetes patients with hypertension Co-morbidity in a developing country: A cross sectional study
Yimam, M. A., Desse, T. A., & Jarso, H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05671 · Cited by 13
Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia
Sorensen, S. V., Frick, K. D., Wade, A., Simko, R. J., & Burge, R. T. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.04.015 · Cited by 14
Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
Trenkwalder, P., Schaetzl, R., Borbas, E., Handrock, R., & Klebs, S. H. G. (2008) · Blood Pressure · doi:10.1080/08038020802488855 · Cited by 13
Hypertension as part of the metabolic syndrome
Cheung, B. M. Y. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.63 · Cited by 13
“The downward trend in blood pressure and cholesterol in the United States of America is highly encouraging”
BackgroundSelf-citation
Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension
Barrios, V., & Escobar, C. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.1.129 · Cited by 13
Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: A review of factorial-design studies
Ram, C. V. S. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802597456 · Cited by 13
Prevalence, awareness, treatment and control of hypertension in Henan Province, China
Fan, L., Feng, S., Han, B., Wang, C.-C., Gao, L., Feng, H.-F., Qi, X., & Zhou, G. (2014) · Australian Journal of Rural Health · doi:10.1111/ajr.12116 · Cited by 13
Blood Pressure Awareness in Austria: Lessons From a 30 Years Horizon
Steiner, S., Dorner, T. E., FODOR, J. G., Kunze, M., & Rieder, A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.257 · Cited by 13
Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States
Elliott, W. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)05025-9 · Cited by 13
Assessing Medication Consultations, Hypertension Control, Awareness, and Treatment Among Elderly Asian Community Dwellers Research and Reports
Lam, A. Y. (2008) · The Consultant Pharmacist · doi:10.4140/tcp.n.2008.795 · Cited by 13
High Blood Pressure
Lackland, D. T. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135541 · Cited by 13
Erratum
&NA; (2011) · Clinical Drug Investigation · doi:10.2165/11533610-000000000-00000 · Cited by 12
The Tripartite Model for Assessing Symptoms of Depression and Anxiety
Xiao, J., Kong, T., McWhinnie, C. M., Yao, S., Zhu, X., Zhao, S., & Duan, S. (2014) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000193 · Cited by 12
Effect of exercise modalities on postexercise hypotension in pre- and postmenopausal women: a systematic review and meta-analysis
Bourvellec, M. L., Delpech, N., Hervo, J., Bosquet, L., & Enéa, C. (2024) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00684.2023 · Cited by 14
Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain l-2-hydroxy acid oxidase
Barawkar, D. A., Bandyopadhyay, A., Deshpande, A. M., Koul, S., Kandalkar, S. R., Patil, P., Khose, G., Vyas, S., Mone, M., Bhosale, S., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.05.020 · Cited by 12
Abdominal obesity, hypertriglyceridemia, hypertriglyceridemic waist phenotype and risk of type 2 diabetes in American adults
Okosun, I. S., & Boltri, J. M. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.003 · Cited by 12
Clinical Characteristics, Treatment Patterns and Outcomes of Hispanic Hypertensive Patients
Campbell, P. T., Krim, S. R., Lavie, C. J., & Ventura, H. O. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.08.006 · Cited by 12
The Role of ARBs Alone or with HCTZ in the Treatment of Hypertension and Prevention of Cardiovascular and Renal Complications
Greathouse, M., & Weir, M. R. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.03.2535 · Cited by 12
An Olmesartan Medoxomil-Based Treatment Algorithm is Effective in Achieving 24-Hour BP Control in Patients with Type 2 Diabetes Mellitus, Regardless of Age, Race, Sex, or Severity of Hypertension
Neutel, J. M., & Kereiakes, D. J. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11584690-000000000-00000 · Cited by 12
The Additive Interaction between Body Mass Index and Hypertension Family History in Han and Yugur: The China National Health Survey (CNHS)
Yu, C., Zhao, H., Pan, L., Zhang, J., Wang, X., Chang, L., Tuo, Y., Xi, J., Liu, B., Wang, Y., et al. (2019) · International Journal of Hypertension · doi:10.1155/2019/8268573 · Cited by 12
Novel Strategies and Targets for the Management of Hypertension
TAYLOR, D. A. H. B., & Abdel‐Rahman, A. A. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57008-6 · Cited by 12
Cost Implications of Improving Blood Pressure Management among U.S. Adults
Nuckols, T. K., Aledort, J. E., Adams, J., Lai, J., Go, M.-H., KEESEY, J. W., & McGlynn, E. A. (2011) · Health Services Research · doi:10.1111/j.1475-6773.2010.01239.x · Cited by 12
Migration and Cognitive Representations of Hypertension in African Immigrant Women
Daramola, O. I., & Scisney‐Matlock, M. (2013) · Western Journal of Nursing Research · doi:10.1177/0193945913504501 · Cited by 14
“This finding corresponded with the literature that has identified increasing age as a risk factor for hypertension (Ong et al., 2007).”
Result
Influence of Living Style and Situation on the Compliance of Taking Antihypertensive Agents in Patients with Essential Hypertension
Mizuno, R., Fujimoto, S., Uesugi, A., Danno, D., Maeda, K., Kanno, M., Matsumura, M., Fujimoto, T., & Nakamura, S. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1016 · Cited by 12
“However, in outpatients with hypertension the percentage of patients with controlled BP to a suitable level is not so high (7, 8).”
Background
Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement
Chang, J. Y., Yang, W., Fellers, T., Kahler, K. H., Orloff, J. J., Xie, J., Tsaneva, M., Yu, A. P., & Wu, E. Q. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.500883 · Cited by 12
Baroreflex Stimulation in Antihypertensive Treatment
Taylor, J. G., & Bisognano, J. D. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0106-6 · Cited by 12
“Though recent data do suggest an improvement in awareness, treatment, and control of hypertension, the overall numbers are still quite alarming, with less than 60% of treated hypertensive patients in the United States reaching a goal BP of less than 140/90 mm Hg [ 6 ].”
Result
Clinical Characteristics and Outcomes in Hypertensive Patients of Hispanic Descent
Aranda, J. M., Calderon, R., & Aranda, J. M. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.08008.x · Cited by 12
Accuracy of Sphygmanometers at Pharmacies
Erdem, D., Erdem, E., Dilek, M., Aydogdu, T., Selim, N., Demiray, F., Sarı, A., & Akpolat, T. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000228936 · Cited by 12
“Hypertension is a common problem affecting more than 1.5 billion people in the world. Lifestyle modifications and use of medications are the main tools in the management of hypertension. Many new drugs have been developed in recent years, but failure to achieve the target blood pressure (BP, ,”
BackgroundInfluential
The lesson of Monsieur Nouma: Effects of a culturally sensitive communication tool to improve health-seeking behavior in rural Cameroon
Gessler, N., Labhard, N. D., Stolt, P., Manga, E., Balo, J., Boffolo, A., & Langewitz, W. A. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.11.007 · Cited by 12
Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
Tetzlaff, E. D., & Davey, M. P. (2013) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2013.4.4.4 · Cited by 12
“More than one-third of patients in the United States who are managed for hypertension have uncontrolled blood pressure (Ong, Cheung, Man, Lau, & Lam, 2007).”
Assessment of medication adherence among hypertensive patients: a cross-sectional study
Bhusal, A., Jadhav, P. R., & Deshmukh, Y. A. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20162480 · Cited by 14
Association between medication adherence and blood pressure control in urban hypertensive patients in central India
Jhaj, R., Gour, P., Kumari, S., & Sharma, S. (2018) · International Journal of Noncommunicable Diseases · doi:10.4103/jncd.jncd_29_16 · Cited by 12
Initial Combination Therapy Compared With Monotherapy in Diabetic Hypertensive Patients
Sowers, J. R., Lastra, G., Rocha, R., Seifu, Y., Crikelair, N., & Levy, D. G. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00003.x · Cited by 12

Authors: Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L.
Affiliations: University of Hong Kong (HK)
ORCID: Ong, Kwok Leung
Cheung, Bernard M.Y.
Lau, Chu Pak
Lam, Karen S.L.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007-01
Volume: 49
Issue: 1
Pages: 69-75
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.0000252676.46043.18
OpenAlex: W2122326747
Cited by: 1,395
References: 35
Citations by year: 2026: 1 · 2025: 8 · 2024: 18 · 2023: 29 · 2022: 25 · 2021: 34 · 2020: 35 · 2019: 39 · 2018: 44 · 2017: 53 · 2016: 55 · 2015: 66 · 2014: 77 · 2013: 103 · 2012: 106
FWCI: 98.77
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords: hypertension prevalence, hypertension awareness, antihypertensive therapy, blood pressure control, temporal trends, age differences, racial and ethnic differences, non-Hispanic blacks, Mexican Americans, adults
MeSH terms: Adult, Aging, Black or African American, Blood Pressure, Female, Goals, Humans, Hypertension, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Nutrition Surveys, United States, Prevalence, Mexican Americans, Black People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks